What You Should Know:
- MediOrbis, a multi-specialty telehealth company today announces a strategic partnership with Kahun, the clinical reasoning tool that performs dynamic clinical assessments at scale.
- The strategic partnership will enable MediOrbis to offer Kahun’s proprietary AI-driven digital intake tool as a part of its comprehensive telehealth platform.
- By offering Kahun’s proprietary AI-driven digital intake tool as a part of its comprehensive
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Merck Invests in Gesund, Launches Medical AI Platform on AWS
What You Should Know:
- Gesund, the company ensuring that medical artificial intelligence (AI) is safe and effective for all, today announced the securing of a strategic investment from Merck as well as a launch of a new commercial platform on Amazon Web Services Marketplace.
- While terms of the investment are not being disclosed, the news signals support for the company's approach as it launches a first of its kind commercial platform on Amazon Web Services Marketplace, immediately
Read More
Encouraging Health Literacy Through Member Advocacy
With the swift rise of digital health tools in the last two years, consumers have easier access to more health information than ever before. But for many, the proliferation of digital health tools has done very little to change their level of health literacy.
Consumers are still confused about their insurance benefits, the resources they can access, and their options for care management, among other things.
As just one example, new research found that 50% of health insurance
Read More
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
What You Should Know:
- Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis.
- Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More
Convenient Scapegoat: Why Hesitancy is Not the Cause of Low Vaccination Rates in Africa
At this year’s World Economic Forum in Davos, the topic of the COVID-19 pandemic and its destructive impact was central to many of the discussions that took place. Among them, was the issue of vaccine hesitancy around the world, especially in underdeveloped nations such as those in Africa. According to Africa CDC, as of September 2022, Africa, the second most-populated continent, has only vaccinated 21% of its people; an inadequate number In comparison to other populated countries such as India
Read More
Half of Infusion Centers Struggling to Keep Up with Demand
What You Should Know:
- LeanTaaS, Inc., an AI-based predictive and prescriptive analytics company in healthcare operations, today announced its The State of Cancer Centers in 2022 Special Report, stemming from a survey conducted in partnership with The Association of Community Cancer Centers (ACCC) in mid-2022.
- With responses from nearly 100 cancer center leaders, hailing from hospitals and health systems across the country, the survey focuses on the operational challenges that infusion
Read More
4 Roadblocks That Are Hindering The Promise of Predictive Analytics
COVID-19 will likely impact and strain healthcare systems for many years to come — possibly even forever. As its attention wanes, we need technology to step in and tell us when and how to act next. What if there was a way to predict the next COVID-19 surge months before it affected operations? How many beds will be available? PPE? Where will you need to allocate additional resources and staff? What other seasonal uptick of disease will it align with? Will our revenue take a
Read More
Ibex Study Finds AI Highly Accurate in Cancer Identification
What You Should Know:
- The latest study from Ibex Medical Analytics and the Institut Curie, published in Nature, demonstrates how AI implementation across pathology labs can significantly improve the outcome of cancer care.
- The study analyzed Ibex’s AI-based quality control solution for breast biopsy review on over 15,000 slides over a diverse cohort. The study found the AI algorithm achieved high accuracy in identifying various types of cancer and 51 different morphological features of
Read More
When Innovation Isn’t Enough: Pharma’s Next Frontier
I met Mark Cuban once. Our conversation didn’t last very long.
It was at a medical conference a few years ago. Cuban felt like a great guy to approach with an idea for a healthcare startup. We were both investors in an automation software startup called Zoba, and I of course knew him from his role on the popular entrepreneurial reality TV series Shark Tank.
A few seconds into our conversation, Cuban paused. “Healthcare is hard,” he sighed. That was his way of politely telling me: for that
Read More
AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity
Ethnic and racial minorities are commonly underrepresented in clinical trials. This problem is so severe that in April, the U.S. Food and Drug Administration (FDA) expanded upon existing guidance to further emphasize recommendations to sponsors developing treatments to increase enrollment from underrepresented populations in the U.S., including African-American, Hispanic, Asian and other persons of color, in clinical trials. In the updated guidance, the FDA provided details on what sponsors
Read More
